about
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...
Read More
19.11
-0.15
(-0.78%)
2.5M
XNAS Volume
XNAS 30 Jul, 2025 4:07 PM (EDT)
Board Meeting
The next board meeting for Liquidia Corp is on 07 Aug 2025 for the purpose of Liquidia Corp Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Liquidia Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..